· 2/13/2001
Biovail Corporation International, Biovail Laboratories,inc., and Galephar P.R., Inc. Ltd. v. Andrx Pharmaceuticals, Inc.
Citations
- 239 F.3d 1297
- 57 U.S.P.Q. 2d (BNA) 1813
- 2001 U.S. App. LEXIS 2092
- 2001 WL 118289
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- using 15 earlier application prosecution history to restrictively construed the term “admixiture” as requiring 16 a homogenous admixture
- “[W]e review both the specification and applicable prosecution history to determine whether the patentee defined claim terminology in a manner inconsistent with its ordinary meaning.”
- \[W]e review both the specification and applicable prosecution history to determine whether the patentee defined claim terminology in a manner inconsistent with its ordinary meaning.\
- “Literal infringement requires a patentee to prove by a preponderance of the evidence that every limitation of the asserted claim is literally met... .”
- “Literal infringement requires a patentee to prove by a preponderance of the evidence that every limitation of the asserted claim is literally met.”
- “As a general proposition, a limitation that does not exist in a claim should not be read into that claim.”
Source: CourtListener parenthetical corpus (CC0).
Judges: Newman, Clevenger, Gajarsa
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.